- Product Details
- Data Display
- Reviews & Citations
- Important Statement
- Resources
1/2




Mogengel Matrix (HC GFR) is intended to be used for in vivo experiments, including patient-derived xenografts, cell-derived xenografts, as well as in vitro angiogenesis assays.
Protein Concentration | ≥ 16 mg/mL, tested by BCA assay. |
Endotoxin Level | < 4.5 EU/mL, tested by LAL assay. |
Subcutaneous Tumor Xenograft | Subcutaneous tumor formation with the addition of Mogengel Matrix (HC GFR) to promote proliferation of tumor cells. *Evaluated Mogengel Matrix Ratio > 50%. |
Angiogenesis | Blood vessel formation is observed, tested by HUVEC angiogenesis assay. *Evaluated Mogengel Matrix: Medium Ratio = 1:0 (original formulation), 2:1, 1:1 (v/v). |
Sterility | No growth observed after 14 days. Testing for the detection of bacteria, fungi, and mycoplasma through cell culture. |
Viral Testing | Tested negative by ELISA, bacterial culture and microscope observation for a total of 19 bacterial and virus strains, and additional murine infectious agents including LDEV. |
Stability | Product is stable for at least two years from date of manufacture when stored at ≤ -20℃. See lot specific Certificate of Analysis for expiration date. |
Shipping Conditions | The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended on the product label. |
Storage | Store at -20℃. Avoid multiple freeze-thaws. Do not store in frost-free freezer. KEEP FROZEN. |